Corcept Therapeutics Announces Insider Trades, Including CEO Joseph Belanoff's Sale of 40,000 Shares

CORCEPT THERAPEUTICS INC. (CORT) announces that Joseph K. Belanoff, Director and Chief Executive Officer, has sold 40,000 shares at $79.77 per share on December 1, 2025. William Guyer, Chief Development Officer, has sold 4,500 shares at $80.90 per share on November 25, 2025, and has purchased 224 shares at $79.78 per share on December 1, 2025. He has also purchased 20,000 shares at $21.65 per share on December 2, 2025, and sold 19,360 shares at $80.05 per share on the same day. In addition, he sold 640 shares at $80.88 per share on December 2, 2025. Joseph D. Lyon, Chief Accounting & Technology Officer, has sold 5,000 shares at $79.53 per share on December 1, 2025, and has purchased 178 shares at $79.78 per share on the same day. He has also sold 110 shares at $79.78 per share on December 2, 2025, and purchased 5,000 shares at $13.56 per share on December 1, 2025. Sean Maduck, President of Corcept Endocrinology, has purchased 20,000 shares at $8.27 per share on December 1, 2025, and has purchased 205 shares at $79.78 per share on the same day. He has also sold 135 shares at $79.78 per share on December 2, 2025, and sold 20,000 shares at $79.52 per share on December 1, 2025.